Willow Biosciences Inc (FRA:3D7)
€ 0.0725 0 (0%) Market Cap: 10.37 Mil Enterprise Value: 10.64 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 33/100

Willow Biosciences Inc Investor Presentation Transcript

Nov 10, 2022 / 07:00PM GMT
Release Date Price: €0.065
Operator

Presentation
Nov 10, 2022 / 07:00PM GMT

=====================
Corporate Participants
=====================
* Glen Akselrod
Bristol Capital Ltd. - IR
* Peter Seufer-Wasserthal
Willow Biosciences Inc. - President, CEO
* Troy Talkkari
Willow Biosciences Inc. - VP, Corporate Development

=====================

Glen Akselrod
Bristol Capital Ltd. - IR

Greetings, ladies and gentlemen, and welcome to the Willow Biosciences investor presentation. (Operator Instructions) As a reminder, today's conference is being recorded. And it is now my pleasure to introduce your host, Mr. Glen Akselrod with Bristol Capital. Thank you. Please go ahead.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot